FeaturedTopics Conflict of Interest
The Stanford University School of Medicine is at the forefront of a movement to increase transparency in medicine and biomedical research. School leaders have taken a series of steps aimed at limiting the potential influence of industry.
News Releases
-
Stanford medical school to provide online disclosure of faculty's consulting activities
The School of Medicine announced today that it would be posting on its Web site the medical- and research-related consulting activities for some 1,200 physicians and affiliated faculty. Full story »
-
Stanford medical school severely restricts industry funding of continuing education for physicians
The Stanford University School of Medicine will no longer accept support from pharmaceutical or device companies for specific programs in continuing medical education, as industry-directed funding may compromise the integrity of these education programs for practicing physicians, officials said. Full story »
-
New Stanford medical center policy limits drug company access and gifts
Stanford University Medical Center has joined a small cadre of other major academic medical centers in enacting a policy aimed at limiting the potential influence of pharmaceutical and other biomedical companies in its day-to-day clinical and educational activities. Full story »
Additional Links
-
Statement from Paul Costello, chief communications officer at Stanford School of Medicine
-
Senator Charles Grassley's Inquiries on Stanford Conflict-of-Interest Policies & Dr. Alan Schatzberg
-
Frequently Asked Questions
Answers about conflict of interest and the school's policies.
-
Conflict of Interest website
Faculty guidelines for avoiding conflicts of interest.
Office of Communication & Public Affairs